John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$191M |
| 2 |
Intel
INTC
|
+$190M |
| 3 |
Qualcomm
QCOM
|
+$188M |
| 4 |
Procter & Gamble
PG
|
+$158M |
| 5 |
PepsiCo
PEP
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$120M |
| 2 |
Costco
COST
|
+$107M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$104M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$98.4M |
| 5 |
Eli Lilly
LLY
|
+$75.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.46% |
| 2 | Consumer Discretionary | 14.39% |
| 3 | Technology | 13.9% |
| 4 | Consumer Staples | 9.5% |
| 5 | Financials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Oneok
OKE
$58.8B
| $9.71M | 0.05% |
292,184
+230,749
| +376% | +$7.52M |
|
402
Alkermes
ALKS
$8.11B
| $9.67M | 0.05% |
498,238
-532,776
| -52% | -$8.65M |
|
|
KDMN
403
DELISTED
Kadmon Holdings, Inc.
KDMN
| $9.65M | 0.05% |
1,884,587
+561,564
| +42% | +$2.52M |
|
404
CALL
Teladoc Health
TDOC
$1.16B
| $9.58M | 0.05% |
50,200
+36,000
| +254% | +$6.31M |
|
|
405
PUT
Teladoc Health
TDOC
$1.16B
| $9.58M | 0.05% |
50,200
+36,700
| +272% | +$6.43M |
|
406
CALL
Beyond Meat
BYND
$254M
| $9.45M | 0.05% |
2,350
-3,317
| -59% | -$11.8M |
|
|
AUY
407
DELISTED
Yamana Gold, Inc.
AUY
| $9.41M | 0.05% |
1,723,973
-2,065,531
| -55% | -$9.87M |
|
408
Bilibili
BILI
$7.14B
| $9.35M | 0.05% |
201,768
-171,006
| -46% | -$5.55M |
|
|
UFS
409
DELISTED
DOMTAR CORPORATION (New)
UFS
| $9.31M | 0.05% |
441,208
+380,010
| +621% | +$8.25M |
|
410
Fastenal
FAST
$58.8B
| $9.29M | 0.05% |
433,720
+366,966
| +550% | +$7.02M |
|
411
AerCap
AER
$23B
| $9.29M | 0.05% |
301,588
+126,911
| +73% | +$3.63M |
|
|
XYZ
412
PUT
Block Inc
XYZ
$49.4B
| $9.23M | 0.05% |
88,000
-270,000
| -75% | -$20.7M |
|
|
NVRO
413
DELISTED
NEVRO CORP.
NVRO
| $9.23M | 0.05% |
77,246
-39,561
| -34% | -$4.69M |
|
414
PUT
JPMorgan Chase
JPM
$935B
| $9.21M | 0.05% |
97,900
+13,300
| +16% | +$1.26M |
|
415
LivaNova
LIVN
$4.34B
| $9.17M | 0.05% |
190,610
+126,691
| +198% | +$6.35M |
|
416
Cintas
CTAS
$81.6B
| $9.15M | 0.05% |
137,384
-264,864
| -66% | -$15.3M |
|
|
417
CALL
Procter & Gamble
PG
$336B
| $9.13M | 0.05% |
76,400
+37,300
| +95% | +$4.35M |
|
|
BNY
418
Bank of New York Mellon
BNY
$108B
| $9.13M | 0.05% |
236,280
+132,000
| +127% | +$4.83M |
|
419
CALL
Target
TGT
$75.1B
| $9.13M | 0.05% |
76,100
+41,000
| +117% | +$4.68M |
|
420
Tradeweb Markets
TW
$22.6B
| $9.12M | 0.05% |
156,788
-194,615
| -55% | -$11.2M |
|
421
Arcus Biosciences
RCUS
$3.86B
| $9.09M | 0.05% |
367,318
+313,047
| +577% | +$8.45M |
|
422
PUT
Okta
OKTA
$23.5B
| $9.05M | 0.04% |
45,200
-53,100
| -54% | -$9.02M |
|
423
iShares Biotechnology ETF
IBB
$10.7B
| $9.04M | 0.04% |
+66,160
| New | +$8.43M |
|
424
Ligand Pharmaceuticals
LGND
$5.71B
| $9.02M | 0.04% |
129,298
-32,490
| -20% | -$2.06M |
|
|
MDLA
425
DELISTED
Medallia, Inc.
MDLA
| $9.01M | 0.04% |
357,149
+190,481
| +114% | +$4.55M |
|
Similar funds
John Overdeck's Q2 2020 Portfolio in Review
As of Q2 2020, John Overdeck held 3,794 positions worth $20.2B, up 64% from $12.3B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
John Overdeck deployed $4.35B of net new capital in Q2 2020, opening 798 new positions and adding to 974 existing holdings. Its largest new stake was Kroger: 3,903,595 shares worth $132M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $104M trimmed.
- John Overdeck's largest Q2 2020 buy was Kroger: 3,903,595 shares worth $132M.
- John Overdeck added most to Lowe's Companies in Q2 2020, an estimated $191M increase.
- John Overdeck's biggest Q2 2020 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $104M.
- John Overdeck fully exited Starbucks in Q2 2020, selling an estimated $120M.
- John Overdeck's ten largest holdings make up 12% of its $20.2B portfolio in Q2 2020.
- John Overdeck opened 798 new positions and closed 913 in Q2 2020.
- John Overdeck's portfolio value rose 64% quarter-over-quarter to $20.2B.
Based on Two Sigma Investments's 13F filing for Q2 2020, filed 14 Aug 2020.